Nachrichten zur Nektar Therapeutics Corp. Aktie

Key PointsNet loss per share (GAAP) of $2.95 improved compared to Q2 2024.GAAP revenue fell 52.3% compared to Q2 2024,…

Nektar (NKTR) delivered earnings and revenue surprises of +5.75% and +3.66%, respectively, for the quarter ended June 2025. Do the…

Nektar Therapeutics stock falls after announcing public offering…

The latest biotech stock to explode in price, Nektar Therapeutics (NASDAQ: NKTR) was quite the outperformer on the stock exchange…

Nektar Therapeutics stock soars after atopic dermatitis drug hits key targets…

Nektar Therapeutics stock soars on upcoming atopic dermatitis data…

…

Nektar (NKTR) delivered earnings and revenue surprises of -22.22% and 40.47%, respectively, for the quarter ended March 2025. Do the…

Nektar (NKTR) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Nektar (NKTR) delivered earnings and revenue surprises of 215.38% and 25.23%, respectively, for the quarter ended December 2024. Do the…

Nektar Therapeutics chief R&D officer sells $48,048 in stock…

…

…

Nektar (NKTR) delivered earnings and revenue surprises of -19.05% and 36.26%, respectively, for the quarter ended June 2024. Do the…

…

Nektar Therapeutics executive sells over $12k in shares…

…

Earnings call: Nektar Therapeutics unveils drug development progress…

…

Nektar Therapeutics secures $30 million in private financing…

…